{"id":30510,"date":"2026-09-15T10:34:34","date_gmt":"2026-09-15T16:34:34","guid":{"rendered":"https:\/\/globalhealthintelligence.com\/?p=30510"},"modified":"2026-09-15T10:34:34","modified_gmt":"2026-09-15T16:34:34","slug":"the-pulse-of-colombias-healthcare-sector-part-iii-the-impact-of-the-crisis-on-medtech-providers","status":"publish","type":"post","link":"https:\/\/globalhealthintelligence.com\/pt-br\/ghi-analysis\/the-pulse-of-colombias-healthcare-sector-part-iii-the-impact-of-the-crisis-on-medtech-providers\/","title":{"rendered":"The Pulse of Colombia\u2019s Healthcare Sector, Part III: The Impact of the Crisis on MedTech Providers"},"content":{"rendered":"[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text css=”” text_direction=”default”]In the third installment of our exclusive analysis, led by Germ\u00e1n Chaparro of Proyekta Data Solutions<\/a>, we shift our focus to the supplier side: Colombia\u2019s medical device and equipment industry. Based on a consolidated study of 70 representative companies, the data reveals how the liquidity crisis plaguing hospitals and insurers has ultimately reached international manufacturers and distributors.<\/p>\n

For parent companies, understanding the systemic risk of this market has become essential. A distributor’s strength can no longer be measured solely by its individual efficiency, but rather by the broader healthcare system’s ability to generate cash.<\/p>\n

1. <\/strong>Stagnant Growth: The Inability to Adjust Prices<\/strong><\/h2>\n

The financial deterioration of hospitals has triggered a domino effect that is stifling growth across the MedTech sector. Companies are facing severe difficulties in adjusting prices for their supplies and equipment, driven entirely by the lack of liquidity among their clients (IPSs, or private healthcare providers).<\/p>\n